Skip to main content
SpringerLink
Log in

Atrazine potentiation of arsenic trioxide‐induced cytotoxicity and gene expression in human liver carcinoma cells (HepG2)

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Recent studies in our laboratory indicated that arsenic trioxide has the ability to cause significant cytotoxicity, and induction of a significant number of stress genes in human liver carcinoma cells, HepG2 [1]. However, similar investigations with atrazine did not show any significant effects of this chemical on HepG2 cells, even at its maximum solubility of 100 μg/mL in 1% dimethyl sulfoxide (DMSO). Further cytogenetic studies were therefore carried out to investigate the combined effects of arsenic trioxide and atrazine on cell viability and gene expression in immortalized human hepatocytes. Cytotoxicity was evaluated using the MTT‐assay for cell viability, while the CAT‐Tox (L) assay was performed to measure the induction of stress genes in thirteen different recombinant cell lines generated from human liver carcinoma cells (HepG2), by creating stable transfectants of different mammalian promoter – chloramphenicol acetyltransferase (CAT) gene fusions. Cytotoxicity experiments yielded LC50 values of 11.9 ± 2.6 μg/mL for arsenic trioxide in de‐ionized water, and 3.6 ± 0.4 μg/mL for arsenic trioxide in 100 μg/mL atrazine; indicating a 3 fold increase in arsenic toxicity associated with the atrazine exposure. Co‐exposure of HepG2 cells to atrazine also resulted in a significant increase in the potency of arsenic trioxide to upregulate a number of stress genes including those of the glutathione‐S‐transferase Ya subunit‐GST Ya, metallothioneinIIa‐HMTIIA, 70‐kDa heat shock protein‐HSP70, c‐fos, 153‐kDa growth arrest and DNA damage (GADD153), 45‐kDa growth arrest and DNA damage (GADD45), and 78‐kDa glucose regulated protein‐GRP78 promoters, as well as the xenobiotic response element‐XRE, tumor suppressor protein response element‐p53RE, cyclic adenosine monophosphate response element‐CRE, and retinoic acid response element‐RARE. No significant changes were observed with respect to the influence of atrazine on the modulation of cytochrome P450 1A1‐CYP 1A1, and nuclear factor kappa (B site) response element‐NFκBRE by arsenic trioxide. These results indicate that co‐exposure to atrazine strongly potentiates arsenic trioxide‐induced cytotoxicity and transcriptional activation of stress genes in transformed human hepatocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tchounwou PB, Wilson BA, Schneider J, Ishaque A: Cytogenetic assessment of arsenic trioxide toxicity in the Mutatox, Ames II, and CATTox assays. Metal Ions Biol Med 6: 89–91, 2000

    Google Scholar 

  2. NAS: Arsenic. National Academy of Science, Washington DC, 1977

    Google Scholar 

  3. U.S. EPA: An Exposure and Risk Assessment for Arsenic. EPA 440/4-85-005. EPA Office of Water Regulations and Standards, Washington DC, 1982

    Google Scholar 

  4. Mock WM, Wai CM: Mobilization of arsenic in contaminated waters. In: J.O. Nriagu (ed). Arsenic in the Environment, part 1: Cycling and Characterization. John Wiley & Sons, Inc., NY, 1994, pp 99–117

    Google Scholar 

  5. Borum DR, Abernathy CO: Human oral exposure to inorganic arsenic. In: W.R. Chappell, C.O. Abernathy, C.R. Cothern (eds). Arsenic Exposure and Health. Science and Technology Press, Northwood, UK, 1994, pp 119–128

    Google Scholar 

  6. IARC: Monographs on the Evaluation of Carcinogenic Risks of Chemicals to Humans. Supplement F. Overall Evaluation of Carcinogenicity. International Agency for Research on Cancer. World Health Organization, Lyon, France, 1987, pp 29–57

    Google Scholar 

  7. IRIS: Integrated Risk Information System. United States Environmental Protection Agency, Washington DC, 1992

    Google Scholar 

  8. Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh S: Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 40: 453–463, 1968

    Google Scholar 

  9. Chen CJ, Chuang YC, Lin TM, Wu HY: Malignant neoplasms among residents of a blackfoot disease endemic area in Taiwan: High-arsenic artesian well water and cancers. Cancer Res 45: 5895–5899, 1985

    Google Scholar 

  10. Chen CJ, Chen CW, Wu MM, Kuo TL: Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Brit J Cancer 66: 888–892, 1992

    Google Scholar 

  11. Tchounwou PB, Wilson B, Ishaque A: Important considerations in the development of public health advisories for arsenic and arsenic-containing compounds in drinking water. Rev Environ Health 24: 211–229, 1999

    Google Scholar 

  12. Tchounwou PB: Health risk assessment and management of arsenic and other toxic and hazardous metals in drinking water. Metal Ions Biol Med 6: 21–23, 2000

    Google Scholar 

  13. Coupe RH, Thurman EM, Zimmerman LR: Relation of usage to the occurrence of cotton and rice herbicides in three streams of the Mississippi Delta. Environ Sci Technol 32: 3673–3680, 1998

    Google Scholar 

  14. Squillace PJ, Thurman, EM, Furlong ET: Ground water as a non point source for atrazine and deethyl atrazine in a river during base flow conditions. Water Resources Res 29: 1719–1729, 1993

    Google Scholar 

  15. Thurman EM, Goolsby DA, Meyer MT, Kolpin DW: Herbicides in surface waters of the midwestern United States: The effects of Spring flush. Environ Sci Technol 25: 1794–1796, 1991

    Google Scholar 

  16. Hallenbeck WH, Cummingham B: In: Pesticides and Human Health. Springer-Verlag, New York, 1985

    Google Scholar 

  17. U.S. EPA: Atrazine Health Advisory. Office of Drinking Water. United States Environmental Protection Agency, Washington DC, 1988

    Google Scholar 

  18. U.S. EPA: Drinking Water and Health: Technical Fact Sheet on Atrazine. United States Environmental Protection Agency, Washington DC, 1999 (on line at: http://www.epa.gov/ OGWDW/dwh/t-soc/ atrazine.html)

    Google Scholar 

  19. Rousselot P, Laboume S, Marolleau JP, Larghero T, Noguera ML, Brouet JC, Fermand JP: Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients. Cancer Res 59: 1041–1048, 1999

    Google Scholar 

  20. Todd MD, Lee MJ, Williams JL, Nalenzny JM, Gee P, Benjamin MB, Farr SB: The CAT-Tox assay: A sensitive and specific measure of stress induced transcription in transformed human liver cells. Fund Appl Toxicol 28: 118–128, 1995

    Google Scholar 

  21. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Applications to proliferation and cytotoxicity assays. J Immunol Meth 65: 55–63, 1983

    Google Scholar 

  22. Solomon KR, Baker DB, Richards RP, Dixon KR, Klaine SJ, LaPoint TW, Kendall RJ, Weisskopf CP, Giddings JM, Giesy JP, Hall LW, Williams WM: Ecological risk assessment of atrazine in north american surface waters. Environ Toxicol Chem 15: 31–76, 1996

    Google Scholar 

  23. Schoolmeester WL, White DR: Arsenic poisoning. Southern Med J 73:198–208, 1980

    Google Scholar 

  24. Gordby MS: Arsenic in human medicine. In: J.O. Nriagu (ed). Arsenic in the Environment, part II: Human Health and Ecosystem Effects. John Wiley & Sons, Inc., New York, 1994, pp 1–16

    Google Scholar 

  25. Saady JJ, Blanke RV, Pollis A: Estimation of the body burden of arsenic in a child fatally poisoned by arsenic weed killer. J Analyt Toxicol 13: 310–312, 1989

    Google Scholar 

  26. ATSDR: Toxicological Profile for Arsenic. TP-92/09. Agency for Toxic Substances and Disease Registry, Center for Disease Control, Atlanta, Georgia, 1993

    Google Scholar 

  27. Fan AM: Assessment of metals in drinking water with specific references to lead, copper, arsenic, and selenium. In: L.W. Chan, L. Magos, T. Suzuki (eds). Toxicology of Metals. Lewis Publishers-CRC Press, Boca Raton, Florida, 1996, pp 39–43

    Google Scholar 

  28. Nordstorm S, Beckman L, Nordenson I: Occupational and environmental risks in and around a smelter in northern Sweden. V. Spontaneous abortion among female employees and decreased birth weight in their offspring. Hereditas 90: 291–296, 1979a

    Google Scholar 

  29. Nordstorm S, Beckman L, Nordenson I: Occupational and environmental risks in and around a smelter in northern Sweden: VI. Congenital malformations. Hereditas 90: 297–302, 1979b

    Google Scholar 

  30. Aschengran A, Zierler S, Cohen A: Quality of community drinking water and the occurrence of spontaneous abortion. Arch Environ Health 44: 283–290, 1989

    Google Scholar 

  31. Fujii-Kuriyama Y, Imataka H, Sogawa K, Yasumoto KI, Kikuchi Y: Regulation of CYP1A1 expression. Fasc Am Soc Exp Biol 6: 706–710, 1992

    Google Scholar 

  32. Neuhold LA, Shirayoshi Y, Ozato K, Jones JE, Nebert DW: Regulation of mouse CYP1A1 gene expression by dioxin: Requirement of two cisacting elements during induction. Mol Cell Biol 9: 2378–2386, 1989

    Google Scholar 

  33. Yao EF, Denison MS: DNA sequence determinants for binding of transformed Ah receptor to a dioxin-responsive enhancer. Biochem 31: 5060–5067, 1992

    Google Scholar 

  34. Desjardins JP, Beard SE, Mapoles JE, Gee P, Thompson JA: Transcriptional activity of quinone methides derived from the tumor promoter butylated hydroxytoluene in HepG2 cells. Cancer Lett 131: 201–207, 1998

    Google Scholar 

  35. Strange RC, Jones PW, Fryer AA: Glutathion-S-transferase: Genetics and role in toxicology. Toxicol Lett 112-113: 357–363, 2000

    Google Scholar 

  36. Rushmore TH, Pickett CB: Xenobiotic responsive elements controlling inducible expression by planar aromatic compounds and phenolic antioxidants. Meth Enzymol 206: 409–420, 1991

    Google Scholar 

  37. Rushmore TH, Pickett CB: Glutathion-S-transferases, structure, regulation and therapeutic implications. J Biol Chem 268: 11475–11478, 1993

    Google Scholar 

  38. Richards RI, Heguy A, Karin M: Structural and functional analysis of the human metallothionein-I gene: Differential induction by metal ions and glucocorticoids. Cell 37: 263–272, 1984

    Google Scholar 

  39. Cherian MB, Howell SB, Imura N, Klaassen CD, Koropatnick K, Lazo J, Waalkes MP: Contemporary issues in toxicology: Role of metallothioneins in carcinogenesis. Toxicol Appl Pharmacol 126: 1–5, 1994

    Google Scholar 

  40. Huang SY, Chan CS, Tang JL, Tien HF, Kuo TL, Huang SF, Yoa YT, Chou WC, Chung CY, Wang CH, Shen MC, Chen YC. Acute and chronic poisoning associated with treatment of acute promyelocytic leukemia. Br J Haematol 103: 1092–1095, 1998

    Google Scholar 

  41. Vogelstein B, Kinzler KW: p53 function and dysfunction. Cell 70: 523–526, 1992

    Google Scholar 

  42. Kastan MB, Onyekwere O, Sidransy D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304–6311, 1991

    Google Scholar 

  43. Zhan Q, Carrier F, Fornace AJ: Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol Cell Biol 13: 442–4250, 1993

    Google Scholar 

  44. Angel P, Karin M: The role of jun, fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072: 129–157, 1991

    Google Scholar 

  45. Sassone-Corsi P, Sission JC, Verma IM: Transcriptional autoregulation of the proto-oncogene fos. Nature 334: 314–319, 1988

    Google Scholar 

  46. Borrelli E, Montmayeur JP, Foulkes NS, Sassone-Corsi P: Signal transduction and gene control: The cAMP pathway. Crit Rev Oncol 3: 321–338, 1992

    Google Scholar 

  47. Hollander MC, Fornace AJ: Induction of fos RNA by DNA-damaging agents. Cancer Res 29: 1687–1692, 1989

    Google Scholar 

  48. Barlett JD, Luethy JD, Carlson SG, Sollott SJ, Holbrook NM: Calcium ionophore A23187 induces expression of the growth arrest and DNA damage inducible CCAAT/enhancer-binding protein (C/EBP)-related gene, gadd153. J Biol Chem 267: 20465–20470, 1992

    Google Scholar 

  49. Luethy JD, Holbrook NJ: Activation of gadd153 promoter by genotoxic agents: a rapid and specific response to DNA damage. Cancer Res 52: 5–10, 1992

    Google Scholar 

  50. Baeuerle PA: The inducible transcription activator NFκB: Regulation by distinct protein subunits. Biochim Biophys Acta 1072: 63–80, 1991

    Google Scholar 

  51. Nelsen B, Hellman L, Shen R: The NF-κB-binding site mediates phorbolester-inducible transcription in non-lymphoid cells. Mol Cell Biol 8: 3526–3531, 1988

    Google Scholar 

  52. Hartl FU, Martin J, Neupert W: Protein folding in the cell: The role of molecular chaperones hsp70 and hsp60. Annual Rev Biophys Biomol Struct 21: 293–322, 1992

    Google Scholar 

  53. Liu H, Lightfoot R, Stevens JL: Activation of heat shock factor by alkylating agent is triggered by glutathione depletion and oxidation of protein thiols. J Biol Chem 271: 4805–3812, 1996

    Google Scholar 

  54. Ovelgonne JH, Souren JEM, Wiegant FAC, Van-Wijk R: Relationship between cadmium-induced expression of heat shock genes, inhibition of protein synthesis and cell death. Toxicol 99: 19–30, 1995

    Google Scholar 

  55. Wooden SK, Li LJ, Navarro D, Qadri I, Pereira L: Transactivation of the grp78 promoter by malfolded proteins, glycosylation block, and calcium ionophore is mediated through a proximal region containing a CCAAT motif which interacts with CTF/NF-I. Mol Cell Biol 11: 5612–5623, 1991

    Google Scholar 

  56. Allenby G, Bosque MT, Saunders M, Kramer S, Speck J: Retinoic acid receptors and retinoic X receptors: Interactions with endogenous retinoic acids. Proc Natl Acad Sci 90: 30–34, 1993

    Google Scholar 

  57. Kirchner SC, Faustman EM: Identifying mechanisms of developmental toxicity: Application of tools from molecular biology. In: A. Puga, K.B. Wallace (eds). Molecular Biology of the Toxic Response. Taylor & Francis, Philadelphia, PA, 1999, pp 411–437

    Google Scholar 

  58. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, Curry CJ, Fernhoff PM, Grix AW, Lott IT: Retinoid acid and embryopathology. New Engl J Med 313: 837–841, 1985

    Google Scholar 

  59. U.S. EPA: Special Report on Ingested Inorganic Arsenic: Skin Cancer and Nutritional Essentiality. Risk Assessment Forum. United States Environmental Protection Agency, Washington DC, 1987

    Google Scholar 

  60. WHO: Guidelines for Drinking Water Quality. World Health Organization, Geneva, Switzerland, 1984

    Google Scholar 

  61. OSHA: Occupational Safety and Health Administration. Fed Reg 54: 2332–2335, 1989

    Google Scholar 

  62. Tchounwou PB, Abdelghani AA, Pramar YV, Heyer LR, Steward CM: Assessment of potential health risks associated with ingesting heavy metals in fish collected from a hazardous-waste contaminated wetland in Louisiana, USA. Rev Environ Health 11: 191–203, 1996

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Molecular Toxicology Research Laboratory, NIH‐Center for Environmental Health, School of Science and Technology, Jackson State University, 1400 Lynch Street, P.O. Box 18540, Jackson, MS, 39217, USA

    Paul B. Tchounwou, Barbara A. Wilson & Ali B. Ishaque

  2. Client Research Laboratory, Xenometrix Inc., Boulder, CO, 80301, USA

    John Schneider

Authors
  1. Paul B. Tchounwou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara A. Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ali B. Ishaque
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul B. Tchounwou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tchounwou, P.B., Wilson, B.A., Ishaque, A.B. et al. Atrazine potentiation of arsenic trioxide‐induced cytotoxicity and gene expression in human liver carcinoma cells (HepG2). Mol Cell Biochem 222, 49–59 (2001). https://doi.org/10.1023/A:1017903005541

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1017903005541

Search

Navigation